Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Structural Heart Devices Market From 2025 To 2034?
The market encompassing devices for structural heart interventions has experienced robust expansion lately; specifically, its valuation is projected to progress from $10.41 billion in the year 2024 to $11.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3% across this timeframe. This upward trajectory witnessed during the past period stems from several factors, including an increasing adoption of surgical methods that involve less intrusion, a high requirement for devices designed for minimally invasive structural heart procedures, continuous educational and training initiatives targeting medical practitioners, escalating overall spending on healthcare services, and a burgeoning inclination among patients toward receiving treatment options that are either non-surgical or involve the least amount of invasiveness.
Anticipation surrounds the structural heart devices sector, forecasting robust expansion ahead, with projections indicating a rise to $16.1 billion by the year 2029, achieving a cumulative yearly growth rate of 9.1%. This surge over the projection window stems from several key factors: an expanding elderly demographic, heightened public consciousness regarding cardiac wellness, the deployment of proactive diagnostic initiatives, supportive financial coverage frameworks for structural heart interventions, and the swift sanctioning of novel structural heart technologies by regulatory bodies. During this forecasted timeline, noteworthy shifts involve a greater embrace of transcatheter valve replacement techniques, continuous innovation in device creation utilizing cutting-edge substances, a mounting focus on tailoring treatments to individual patient needs, increased utilization of combined procedural approaches, and the incorporation of remote patient observation alongside telehealth services.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp
What Are The Top Growth Drivers Impacting The Structural Heart Devices Market Outlook?
The escalating occurrence of afflictions related to the heart and blood vessels is anticipated to stimulate the expansion of the structural heart device sector moving ahead. These cardiovascular ailments, encompassing issues like blocked arteries, cardiac events, and cerebrovascular incidents, are seeing a steady worldwide climb, largely attributable to inactive living patterns, substandard eating practices, increasing body mass issues, tobacco use, and an aging general populace. Structural heart technologies serve to manage these conditions by mending or substituting compromised cardiac valves, rectifying inherent structural anomalies, and ultimately enhancing cardiac performance and results for those afflicted. To illustrate this burden, data disclosed in September 2024 by the British Heart Foundation, a UK research foundation focused on heart health, indicated that roughly 7.6 million individuals across the United Kingdom suffer from heart and circulatory illnesses, with the numbers broken down into roughly 4 million men and 3.6 million women battling these problems. These maladies are accountable for an estimated twenty-seven percent of all fatalities within the United Kingdom, amounting to over 170,000 lost lives annually, or approximately 480 fatalities every twenty-four hours, which translates to one life lost in every three-minute interval. Consequently, the increasing incidence of cardiovascular diseases is serving as a major impetus for the structural heart device market’s upward trajectory.
What Are The Major Segment Categories Driving The Structural Heart Devices Market Growth?
The structural heart devicesmarket covered in this report is segmented –
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults
Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems
Which Market Trends Are Creating New Opportunities In The Structural Heart Devices Industry?
In the realm of the structural heart devices market, leading corporations are actively innovating by creating less invasive surgical techniques and apparatuses aimed at boosting patient recovery speeds, improving results for those treated, and broadening the available interventions for various structural heart ailments. A notable technology in this space is the self-expanding transcatheter aortic valve implantation (TAVI) system, engineered to position and fix a replacement valve within the existing aortic valve structure without the necessity of balloon expansion. To illustrate this progress, in December of 2022, Abbott Laboratories, an American entity producing medical implements and healthcare supplies, rolled out its newest generation TAVI system, branded Navitor, within the Indian market; this system is specifically designed for high or prohibitive surgical risk patients afflicted with severe aortic stenosis and incorporates novel attributes like a distinctive configuration intended to mitigate valve regurgitation, thereby bolstering Abbott’s collection of less invasive transcatheter treatments for cardiac pathologies, granting both medical practitioners and patients more choice. What distinguishes Navitor is its unique status as the only self-expanding TAVI device featuring intra-annular leaflets alongside generously sized frame cells, which significantly eases subsequent access to coronary arteries for potential future procedures related to coronary artery disease, furthermore, this modernized structure contributes to superior hemodynamics, ensuring optimal blood circulation.
Which Industry Leaders Are Driving Innovation Across The Structural Heart Devices Market?
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report
Which Region Is Expected To Witness The Fastest Growth In The Structural Heart Devices Market?
North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Structural Heart Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp
Browse Through More Reports Similar to the Global Structural Heart Devices Market 2025, By The Business Research Company
Structural Heart Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report
Prosthetic Heart Valve Devices And Equipment Global Market Report 2025
Hearth Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hearth-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
